SHYFT Analytics

@SHYFTAnalytics is the leader in cloud-based #DataAnalytics and mobile solutions for the global #LifeSciences industry.

[SHYFT Analytics @SHYFTAnalytics]

Watch Bruno Lempernesse, SVP & GM, Commercial Data Solutions, Acorn AI, talk about SHYFT Analytics adopt the Acorn AI brand & how this will further advance our mission of accelerating the delivery of actionable insights, from molecule to commercialization
https://t.co/MZEFXFbQtW

[SHYFT Analytics @SHYFTAnalytics]

SHYFT Analytics will officially adopt the Acorn AI, by Medidata brand. The innovative commercial + #dataanalytics tech + services valued by SHYFT customers will operate as the Commercial Data Solutions (CDS) team at Acorn AI. Learn more: https://t.co/lwrMn62vsn

#clinicaltrials

[Medidata @Medidata]

#Webinar: Does your org struggle when it comes to the FDA + other competent authorities? Join @Alethea_Wieland as she highlights the key advantages of meeting with the #FDA early in the process to set your #roadmap to success. Reg today: https://t.co/5QbZNa91ga
#clinicaltrials

[Glen de Vries @CaptainClinical]

We were lucky enough to have @momfrates at Medidata NEXT a couple years ago. The incredible impact of advocates like @PeteFrates3 on the advancement of science and medicine is something to cherish, and always -- albeit sadly in this moment -- remember. https://t.co/qONcHexBEP

[SHYFT Analytics @SHYFTAnalytics]

Download our #whitepaper to see how #biopharma companies are turning to RWE to provide enterprise value across both clinical and commercial use cases while driving increased time and cost efficiencies>>>

https://t.co/ReD2VeEnV4

#pharma #lifesciences #RWE

[Medidata @Medidata]

As #lifescience organizations turn data into insights & insights into improved patient outcomes, the roles of CIO & CTO are evolving. Our CIO Rama Kondru is now #CTO too. Watch an interview with him on why that matters for #healthcare: https://t.co/fXfnusNhhw

#DigitalInovation

[SHYFT Analytics @SHYFTAnalytics]

The State of #RWE: Research reveals that RWE has shown immense value for companies that have invested the resources to track, measure, and apply it meaningfully. Here are some more interesting facts:

https://t.co/uFnPXuJl2H

#Data #lifesciences #clinicaltrials #Clinicalresearch

[SHYFT Analytics @SHYFTAnalytics]

Wishing our customers, partners, staff and their families a very happy thanksgiving 🦃🍁🍂

#HappyThanksgiving

[SHYFT Analytics @SHYFTAnalytics]

#OnDemandWebinar: Tune in to hear our experts discuss how the use of #technology can be leveraged to enable the standardization, transparency, & replicability of #RWD research. Download here: https://t.co/JHvTk7T8Xn

[SHYFT Analytics @SHYFTAnalytics]

It's not a surprise that the need for #RWE is growing in #biopharma. Studies show that the global market will see a 15% annual growth rate from 2019-2024. We have conducted our own research to see how biopharmas are handling the current state of RWE. https://t.co/ZDYspHlmON

[SHYFT Analytics @SHYFTAnalytics]

#ICYMI - Watch our latest on-demand #webinar as SHYFT's subject matter experts discuss how #data and #analytics can be used to gain a competitive edge when it comes to maximizing brand value and exceeding peak year sales.

https://t.co/RS0YQAeDJk

#pharma #lifesciences

[SHYFT Analytics @SHYFTAnalytics]

Download our #whitepaper to see how #biopharma companies are turning to RWE to provide enterprise value across both clinical and commercial use cases while driving increased time and cost efficiencies>>>

https://t.co/Kgg3NSsCzI

#pharma #lifesciences #RWE

[SHYFT Analytics @SHYFTAnalytics]

Yesterday at #isporeurope our team presented 4 posters. Be sure to visit us during our remaining 3 poster sessions this week. #isporeurope #rwe

[SHYFT Analytics @SHYFTAnalytics]

@drjr1979 shared, "Stephens et al estimated that we'll generate so many genome sequences per year by 2025 that it will require 1 trillion years of CPU time to process" #ISPOREurope #precisionmedicine

[Medidata @Medidata]

#ISPOREurope: Here's one of @SHYFTAnalytics's poster presentations for today, Nov 4, where we'll discuss: evaluation of missing data imputation strategies in #clinicaltrial and EMR #data using standardized data models. @ISPORorg

https://t.co/Xh6XhBHnba

[SHYFT Analytics @SHYFTAnalytics]

#ISPOREurope - Join Josh Ransom, Ph.D. Head of RWE, Implementation & Innovation at AcornAI @ISPORorg as he discusses the critical role of next generation testing, #NGT, in #PrecisionMedicine, and how it affects its future needs for growth and expansion.

https://t.co/ewtYGeXmk9

[SHYFT Analytics @SHYFTAnalytics]

Day 1 at #ISPOREurope: Make sure to stop by our booth #C3-077 to meet with our RWE team. Hope to see you there @ISPORorg!

https://t.co/hiNOv3m0tw

#RWE #pharma #lifesciences #Meetus

[SHYFT Analytics @SHYFTAnalytics]

#ISPOREurope: Join our #posterpresentation at @ISPORorg as we talk about patterns and prediction for cognitive decline in Alzheimer's patients

https://t.co/hiNOv3m0tw

#PatientsFirst #Alzheirmers #clinicaltrials #pharma

[SHYFT Analytics @SHYFTAnalytics]

#ISPOREurope: another great #posterpresentation at @ISPORorg to discuss treatment patterns and injectable multiple sclerosis disease

https://t.co/hiNOv3m0tw

#PatientsFirst #multiplesclerosis #clinicaltrials #pharma

[SHYFT Analytics @SHYFTAnalytics]

#ISPOREurope: Join our #posterpresentation at @ISPORorg as our industry experts discuss using 3C-HF prognostic score tool to predict worsening cardiac function among patients.

https://t.co/hiNOv3m0tw

#PatientsFirst #HeartDisease #clinicaltrials #pharma